Gentile A T, Feliciano P D, Mullins R J, Crass R A, Eidemiller L R, Sheppard B C
Department of Surgery, Oregon Health Sciences University, Portland, USA.
J Am Coll Surg. 1998 Mar;186(3):313-8. doi: 10.1016/s1072-7515(98)00012-x.
Necrotizing pancreatitis is a poorly understood process that has been treated by a variety of surgical approaches. Despite advances in operative interventions and critical care, this disease often requires prolonged resource allocation and continues to cause substantial morbidity, with mortality rates ranging from 11% to 40%. We report on our recent series of patients with necrotizing pancreatitis and our experience with the use of an absorbable mesh in a subset of these patients to facilitate their surgical care.
From 1985 to 1994, 40 patients with culture-proved necrotizing pancreatitis underwent operative debridement and drainage. Surgical outcomes were compared among patients who underwent a single debridement and drainage, those requiring multiple procedures, and those having placement of polyglycolic acid mesh.
The overall hospital mortality rate was 30%. The mean length of hospital stay was 35 days. The rate of infected pancreatic necrosis was 60%, with a mortality rate of 45% in patients having infected pancreatic tissue at surgery. Patients without infected pancreatic tissue at surgery had a mortality rate of 6% (p = 0.03). Eleven patients requiring multiple operations had placement of absorbable polyglycolic acid mesh. Clinic followup was possible in five of six survivors who underwent mesh closure. Abdominal-wall hernias developed in two patients and were repaired electively, and three patients had spontaneous closure by granulation without abdominal-wall hernias. The average number of operations for debridement and drainage was 2.5 (range, 1-15). Patients with limited pancreatic necrosis required a single operative debridement and drainage, and this was associated with improved outcomes.
Necrotizing pancreatitis remains an important challenge in surgical care. It requires prolonged hospitalization, costly resources, and causes substantial morbidity and mortality. Our patients with infected pancreatic necrosis or clinical deterioration underwent open staged necrosectomy and debridement. Those patients requiring repeat laparotomy often had placement of polyglycolic acid mesh. This provided open drainage of the abdominal cavity and simplified further care by allowing easy abdominal access for repeat drainage procedures, often performed in the intensive care unit. These patients had a high rate of fistula formation, which may be decreased by changes in wound care. Polyglycolic acid mesh is a useful adjunct in the surgical care of selected patients with necrotizing pancreatitis.
坏死性胰腺炎是一个尚未被充分了解的过程,已经采用了多种外科手术方法进行治疗。尽管手术干预和重症监护取得了进展,但这种疾病通常需要长期的资源分配,并且仍然会导致大量的发病情况,死亡率在11%至40%之间。我们报告了我们最近收治的一系列坏死性胰腺炎患者,以及我们在其中一部分患者中使用可吸收网片以促进其外科治疗的经验。
从1985年至1994年,40例经培养证实为坏死性胰腺炎的患者接受了手术清创和引流。对接受单次清创和引流的患者、需要多次手术的患者以及放置聚乙醇酸网片的患者的手术结果进行了比较。
总体医院死亡率为30%。平均住院时间为35天。感染性胰腺坏死率为60%,手术时存在感染性胰腺组织的患者死亡率为45%。手术时无感染性胰腺组织的患者死亡率为6%(p = 0.03)。11例需要多次手术的患者放置了可吸收聚乙醇酸网片。6例接受网片封闭术的幸存者中有5例获得了临床随访。2例患者发生腹壁疝并择期进行了修复,3例患者通过肉芽组织自发封闭,未发生腹壁疝。清创和引流的平均手术次数为2.5次(范围为1至15次)。胰腺坏死局限的患者需要单次手术清创和引流,这与更好的结果相关。
坏死性胰腺炎仍然是外科治疗中的一项重要挑战。它需要长期住院、耗费大量资源,并导致大量发病和死亡。我们的感染性胰腺坏死或临床病情恶化的患者接受了开放性分期坏死组织切除术和清创术。那些需要再次剖腹手术的患者通常放置了聚乙醇酸网片。这提供了腹腔的开放引流,并通过允许在重症监护病房经常进行的重复引流操作方便地进入腹腔而简化了进一步的护理。这些患者的瘘管形成率很高,通过改变伤口护理可能会降低。聚乙醇酸网片是坏死性胰腺炎特定患者外科治疗中的一种有用辅助手段。